Press release 📈 Stocks 🌍 GLOBAL

AkzoNobel and Axalta Target Early 2027 Merger Close Despite UK CMA Review

AkzoNobel and Axalta remain confident in an early 2027 merger completion, proposing a divestment of European vehicle refinish assets to resolve UK competition concerns.

🕐 1 min read

2 assets impacted (Stocks). Net bias: 2 Bullish, 0 Bearish, 0 Neutral. Strongest signal: AXTA ↑ 4/10 (60% confidence).

📊 Affected Assets (2)

AXTA
Bullish 🤖 60%
📅 Short-term 🌍 US · Explicit

The UK CMA raised Phase 1 competition concerns only about UK vehicle refinish coatings, but both companies propose the same remedy package already agreed with the European Commission (divestment of AkzoNobel's European and UK VR coatings business) and state they remain confident the merger will close by early 2027. For Axalta holders this reduces deal-break risk, though the CMA has not yet accepted the remedy.

Catalysts
  • ▲ CMA Phase 1 decision limited to UK vehicle refinish coatings
  • ▲ Companies propose the remedy package already agreed with the European Commission
Risk Factors
  • ▼ CMA has not yet approved the remedy; Phase 1 concerns could escalate to a Phase 2 review
  • ▼ Closing depends on continued constructive engagement with both the European Commission and the CMA
AKZA
Bullish 🤖 60%
📅 Short-term 🌍 NL · Explicit

The CMA's Phase 1 concerns are confined to UK vehicle refinish coatings, and AkzoNobel will remedy them by divesting its European VR coatings business including the UK — a package already agreed with the European Commission. The companies reaffirm completion by early 2027, supporting the deal case, though UK approval is not yet secured.

Catalysts
  • ▲ CMA concerns limited to UK vehicle refinish coatings only
  • ▲ Same remedy package as already agreed with the European Commission (divestment of AkzoNobel's European VR business)
Risk Factors
  • ▼ Divestment of the European and UK VR coatings business reduces the combined scope
  • ▼ CMA has not yet accepted the remedy and could escalate the review

🧭 Full analysis of these assets

🎯 Key Takeaways

  • The UK CMA identified competition concerns specifically regarding the supply of vehicle refinish coatings in the UK.
  • Companies are proposing the same remedy package previously agreed with the European Commission, involving the divestment of AkzoNobel’s European vehicle refinish business.
  • The combined entity is expected to generate approximately $17 billion in revenue.
  • Both companies reaffirmed their target to complete the merger by early 2027.

📝 Executive Summary

AkzoNobel and Axalta are addressing UK Competition and Markets Authority concerns regarding vehicle refinish coatings by proposing the same remedy package already accepted by the European Commission. The companies plan to divest AkzoNobel’s European vehicle refinish business to satisfy regulators and maintain their target to complete the merger by early 2027.

❓ FAQ

AXTA · Does the UK regulator's decision put the AkzoNobel-Axalta merger at risk?

The companies say the CMA's concerns are limited to UK vehicle refinish coatings and that they will address them with the same remedy already agreed with the European Commission, remaining confident the merger completes by early 2027.

AKZA · What does the UK review mean for the merged company?

AkzoNobel will divest its European vehicle refinish coatings business, including the UK unit, as the remedy — the same package already agreed with the European Commission — and the companies still expect the merger to complete by early 2027.